DXT · Class II · 21 CFR 870.1650

FDA Product Code DXT: Injector And Syringe, Angiographic

Leading manufacturers include Shandong Int Medical Instruments Co., Ltd., Precision Medical Plastics , Ltd. and Shenzhen Boon Medical Supply Co., Ltd..

207
Total
207
Cleared
145d
Avg days
1978
Since
Growing category - 8 submissions in the last 2 years vs 1 in the prior period
Review times increasing: avg 206d recently vs 142d historically

FDA 510(k) Cleared Injector And Syringe, Angiographic Devices (Product Code DXT)

207 devices
1–24 of 207

About Product Code DXT - Regulatory Context

510(k) Submission Activity

207 total 510(k) submissions under product code DXT since 1978, with 207 receiving FDA clearance (average review time: 145 days).

Submission volume has increased in recent years - 8 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under DXT have taken an average of 206 days to reach a decision - up from 142 days historically. Manufacturers should account for longer review timelines in current project planning.

DXT devices are reviewed by the General Hospital panel. Browse all General Hospital devices →